| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alemtuzumab and the value of neurological research
|
The Lancet Neurology,
|
|
2014
|
13 |
3 |
p. 233-
1 p.
|
article
|
| 2 |
A new encephalitis with GABAA receptor antibodies
|
Hirsch, Lawrence J
|
|
2014
|
13 |
3 |
p. 239-240
2 p.
|
article
|
| 3 |
Cognitive and neurological aspects of sex chromosome aneuploidies
|
Hong, David S
|
|
2014
|
13 |
3 |
p. 306-318
13 p.
|
article
|
| 4 |
Corrections
|
|
|
2014
|
13 |
3 |
p. 240-
1 p.
|
article
|
| 5 |
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
|
Leist, Thomas P
|
|
2014
|
13 |
3 |
p. 257-267
11 p.
|
article
|
| 6 |
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
|
Low, Phillip A
|
|
2014
|
13 |
3 |
p. 268-275
8 p.
|
article
|
| 7 |
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
|
Petit-Pedrol, Mar
|
|
2014
|
13 |
3 |
p. 276-286
11 p.
|
article
|
| 8 |
Indian film on epilepsy busts myths
|
Sharma, Dinesh C
|
|
2014
|
13 |
3 |
p. 245-
1 p.
|
article
|
| 9 |
Mood and behavioural effects of subthalamic stimulation in Parkinson's disease
|
Castrioto, Anna
|
|
2014
|
13 |
3 |
p. 287-305
19 p.
|
article
|
| 10 |
Neurobehavioural effects of developmental toxicity
|
Grandjean, Philippe
|
|
2014
|
13 |
3 |
p. 330-338
9 p.
|
article
|
| 11 |
New evidence for teriflunomide in multiple sclerosis
|
Kieseier, Bernd C
|
|
2014
|
13 |
3 |
p. 234-235
2 p.
|
article
|
| 12 |
News in brief
|
|
|
2014
|
13 |
3 |
p. 246-
1 p.
|
article
|
| 13 |
New treatments for multiple sclerosis: at what long-term risk?
|
Cameron, Michelle H
|
|
2014
|
13 |
3 |
p. 235-237
3 p.
|
article
|
| 14 |
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Confavreux, Christian
|
|
2014
|
13 |
3 |
p. 247-256
10 p.
|
article
|
| 15 |
Paul Krack: deeper brain stimulation
|
Holmes, David
|
|
2014
|
13 |
3 |
p. 243-
1 p.
|
article
|
| 16 |
Plagues and pesticides
|
Goodrick, Steven
|
|
2014
|
13 |
3 |
p. 244-
1 p.
|
article
|
| 17 |
Rifampicin for multiple system atrophy
|
Wenning, Gregor K
|
|
2014
|
13 |
3 |
p. 237-239
3 p.
|
article
|
| 18 |
Should your patient be doing yoga?
|
Burton, Adrian
|
|
2014
|
13 |
3 |
p. 241-242
2 p.
|
article
|
| 19 |
Targeting the β secretase BACE1 for Alzheimer's disease therapy
|
Yan, Riqiang
|
|
2014
|
13 |
3 |
p. 319-329
11 p.
|
article
|
| 20 |
Thomas Leist
|
|
|
2014
|
13 |
3 |
p. 244-
1 p.
|
article
|
Journal description